Scotia Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Sell
5,590
-1,575
-22% -$145K ﹤0.01% 676
2025
Q4
$644K Sell
7,165
-1,227
-15% -$116K ﹤0.01% 627
2025
Q3
$827K Sell
8,392
-3,351
-29% -$332K ﹤0.01% 592
2025
Q2
$1.07M Sell
11,743
-374
-3% -$36.2K 0.01% 514
2025
Q1
$1.37M Sell
12,117
-52
-0.4% -$5.56K 0.01% 460
2024
Q4
$1.29M Sell
12,169
-257
-2% -$27.6K 0.01% 478
2024
Q3
$1.34M Buy
12,426
+120
+1% +$13.1K 0.01% 455
2024
Q2
$1.34M Sell
12,306
-107
-0.9% -$12.6K 0.01% 447
2024
Q1
$1.64M Buy
12,413
+97
+0.8% +$12.1K 0.01% 405
2023
Q4
$1.5M Buy
12,316
+465
+4% +$51.9K 0.01% 398
2023
Q3
$1.33M Buy
11,851
+270
+2% +$34.3K 0.01% 404
2023
Q2
$1.69M Sell
11,581
-1,442
-11% -$196K 0.01% 369
2023
Q1
$1.68M Sell
13,023
-1,697
-12% -$213K 0.01% 370
2022
Q4
$1.88M Buy
+14,720
New +$1.71M 0.01% 356
2020
Q4
Sell
-1,536
Closed -$203K 794
2020
Q3
$203K Buy
+1,536
New +$201K ﹤0.01% 656

Other funds holding ZBH

Scotia Capital's ZBH Position: Q1 2026 in Review

Scotia Capital reduced its Zimmer Biomet (ZBH) stake by 22% in Q1 2026, selling an estimated $145K and leaving 5,590 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Scotia Capital first reported a position in ZBH in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.88M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Scotia Capital held 5,590 shares of Zimmer Biomet worth $505K as of Q1 2026.
  • Scotia Capital sold 1,575 Zimmer Biomet shares in Q1 2026, an estimated $145K.
  • Zimmer Biomet made up ﹤0.01% of Scotia Capital's portfolio in Q1 2026, its #676 holding.
  • Scotia Capital first reported a position in Zimmer Biomet in Q3 2020 and has held it in 15 quarters since.
  • Scotia Capital's Zimmer Biomet position peaked at $1.88M in Q4 2022.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.